相关实验视频

Updated: May 27, 2025

An Affordable HIV-1 Drug Resistance Monitoring Method for Resource Limited Settings

An Affordable HIV-1 Drug Resistance Monitoring Method for Resource Limited Settings

Published on: March 30, 2014

在美国中西部的一家艾滋病毒/PrEP诊所使用多西环素暴露后预防

Shawnalyn W Sunagawa¹, Gabriel Codling¹, Elizabeth Lyden²

¹College of Pharmacy, University of Nebraska Medical Center, Omaha, Nebraska, USA.

Open forum infectious diseases

|February 18, 2025

概括

在我们的诊所中,多西环林暴露后预防处方的坚持率为70%. 大多数不遵守的原因是错过了性传播感染查,突出了改善后续检查的必要性.

科学领域:

传染性疾病传染性疾病
公共卫生公共卫生
药理学药理学是指药理学的学科.

背景情况:

多西环素暴露后预防 (DoxyPEP) 越来越多地用于预防性传播疾病.
确保遵守处方协议对于DoxyPEP疗效至关重要.
监测和后续行动是DoxyPEP管理的重要组成部分.

研究的目的:

评估在临床环境中遵守多西环林暴露后预防的处方方案.
为了确定不遵守DoxyPEP处方的原因.
强调对DoxyPEP进行适当的后续和监测的重要性.

主要方法:

对多西环林暴露后预防处方的回顾性图表审查.
基于既定临床指导方针的坚持率的分析.
不遵守原因的分类,重点是STI查完成.

主要成果:

在70%的病例中,观察到适当的,符合协议的多西环林暴露后预防处方.
不坚持处方的主要原因是错过了性传播感染查,占不坚持病例的89%.
很大一部分的DoxyPEP处方没有完全遵守协议.

结论:

虽然大多数多西环林暴露后预防处方是合规的,但很大一部分不是.
错过的性传播感染查是适当的DoxyPEP处方的关键障碍.
持续增加的DoxyPEP使用需要加强后续和监测策略,以确保最佳的患者结果.

关键词:

克拉米迪亚菌落状虫病 (chlamydia trachomatis) 是一种感染性疾病.尼塞里亚淋病菌 (Neisseria gonorrhoeae) 是一种传染病.它们中的一个是Treponema pallidum.多克西环素是什么?多克西环素是什么?暴露后预防暴露后预防性传播感染性传播感染

更多相关视频

Humanized NOG Mice for Intravaginal HIV Exposure and Treatment of HIV Infection

Humanized NOG Mice for Intravaginal HIV Exposure and Treatment of HIV Infection

Published on: January 31, 2020

Rapid Screening of HIV Reverse Transcriptase and Integrase Inhibitors

Rapid Screening of HIV Reverse Transcriptase and Integrase Inhibitors

Published on: April 9, 2014

相关概念视频

Dose-Response Relationship: Potency and Efficacy

Dose-Response Relationship: Potency and Efficacy

The potency of a drug is the measure of its ability to produce a biological response and can be compared by looking at the half-maximum effective concentration or EC50 values of different drugs. A lower EC50 value indicates higher potency of the drug. In the dose–response curve of two antihypertensive drugs, candesartan and irbesartan, a significant difference is observed in their EC50 values. A lower EC50 value for candesartan indicates that it is more potent than irbesartan, as it...